CBF - ANSWER cerebral blood flow
50-60 mL / 100 g / min
CBV - ANSWER cerebral blood volume
4-5 mL / 100 g
platelet count - ANSWER 140k-440k per uL of blood
INR - ANSWER International Normalized Ratio
0.8-1.2
PTT - ANSWER partial thromboplastin time
25-35 seconds
BUN - ANSWER 7-25 mg / dL
creatinine - ANSWER 0.5-1.5 mg / dL
GFR (men) - ANSWER 70 +/- 14
GFR (women) - ANSWER 60 +/- 10
PT - ANSWER prothrombin time
12-15 seconds
1
, max IV contrast for a child shouldn't exceed - ANSWER 3 mL / kg of body weight
excretion half-life of IV contrast - ANSWER 1-2 hours
barium sulfate concentration - ANSWER 1-3%
water-soluble oral contrast for abdomen/pelvis should contain ________% iodine - AN-
SWER 2-5
high-osmolar contrast = _________ mOsm / kg of water - ANSWER 1000-2400
risk factors for contrast-induced nephrotoxicity (CIN) - ANSWER diabetes
myoloma
cardiac disease
advanced age
hepatic contrast enhancement phases - ANSWER arterial phase
portal/hepatic venous phase
equilibrium phase
delayed phase
arterial phase of hepatic contrast enhancement - ANSWER 25-35 seconds
hypervascular tumors
portal/hepatic venous phase of hepatic contrast enhancement - ANSWER 60-70 seconds
hypovascular lesions & masses
2
50-60 mL / 100 g / min
CBV - ANSWER cerebral blood volume
4-5 mL / 100 g
platelet count - ANSWER 140k-440k per uL of blood
INR - ANSWER International Normalized Ratio
0.8-1.2
PTT - ANSWER partial thromboplastin time
25-35 seconds
BUN - ANSWER 7-25 mg / dL
creatinine - ANSWER 0.5-1.5 mg / dL
GFR (men) - ANSWER 70 +/- 14
GFR (women) - ANSWER 60 +/- 10
PT - ANSWER prothrombin time
12-15 seconds
1
, max IV contrast for a child shouldn't exceed - ANSWER 3 mL / kg of body weight
excretion half-life of IV contrast - ANSWER 1-2 hours
barium sulfate concentration - ANSWER 1-3%
water-soluble oral contrast for abdomen/pelvis should contain ________% iodine - AN-
SWER 2-5
high-osmolar contrast = _________ mOsm / kg of water - ANSWER 1000-2400
risk factors for contrast-induced nephrotoxicity (CIN) - ANSWER diabetes
myoloma
cardiac disease
advanced age
hepatic contrast enhancement phases - ANSWER arterial phase
portal/hepatic venous phase
equilibrium phase
delayed phase
arterial phase of hepatic contrast enhancement - ANSWER 25-35 seconds
hypervascular tumors
portal/hepatic venous phase of hepatic contrast enhancement - ANSWER 60-70 seconds
hypovascular lesions & masses
2
